BioPharma
09 July, 2025 | Wednesday | Opinion
FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
The FDA’s recent decision to cut its workforce by 20 percent has raised concerns across the biopharma industry, with experts warning of inevitable delays in drug development and approvals. Some companies ...
Lab
15 July, 2025 | Tuesday | News
Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System
Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precision oncology research. The Oncomi...
BioTech
15 July, 2025 | Tuesday | News
Waters Corporation to Combine with BD’s Biosciences & Diagnostic Solutions, Creating a Global Life Sciences and Diagnostics Leader
Waters Corporation , a global leader in analytical instruments and software, announced it has entered into a definitive agreement to combine with BD’s Biosciences & Diagnostic Solutions business....
Contract Services
01 July, 2025 | Tuesday | News
WuXi Biologics Launches WuXiHigh™2.0 to Enable Record-Setting High-Concentration Biologic Formulations
The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation stabil...
Consumer Health
14 July, 2025 | Monday | News
Using NLP-Driven Decision Support in Emergency Health Assistance
According to the US Department of Transportation, over 40,000 lives were lost in roadway deaths in 2023. The CDC reports that the country saw approximately 43.5 million injury-related hospital visits in...
White Paper
14 July, 2025 | Monday | News
Using NLP-Driven Decision Support in Emergency Health Assistance
Product Spot Light
15 July, 2025 | Tuesday | News
Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System
Premium Article
09 July, 2025 | Wednesday | Interview
Unlocking Solubility as Lubrizol's Excipients Power the Next Generation of Drug Delivery
Bio Invest
15 July, 2025 | Tuesday | News
Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders
Biopharma APAC Infomercial
Most Read
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
